Please assess the completion status of the following clinical trial:

Trial Title: Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder - 1

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~Subjects: 100 stable outpatients with schizophrenia and schizoaffective disorder and nicotine dependence. All subjects will meet the following inclusion criteria:~* Patients who are able to provide informed consent~* Patients will meet DSM-IV diagnostic criteria for Nicotine Dependence and Schizophrenia or Schizoaffective disorder~* Patients will be stable on their current antipsychotic regimen and will be interested in treatment for both their psychiatric and nicotine dependence~Exclusion Criteria:~* Potential subjects meeting the following criteria will be excluded:~* Patients with history of clinically significant angina or unstable angina pectoris~* Patients with severe CAD or recent myocardial infarction (within last 6 months)~* Patients with evidence or history of other severe medical illness (hematologic, renal or neoplastic)~* Patients who represent a serious suicide risk, including recent suicidal behavior or attempt within the last thirty days~* Patients with history of severe skin allergies or chronic dermatoses~* Concomitant use of clonidine or bupropion~* Pregnant females

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).